Michael Peregrine and Jeffrey Brennan wrote this bylined article on new FTC antitrust guidance regarding health system use of interlocking directors and officers, and other interlocking relationships, to establish collaborative relationships. “The antitrust concern arises when the collaborative arrangements that involve interlocking directors are between organizations that could reasonably be considered by the government as competitors” under the Clayton Act, the authors wrote.
